Oncolytic adenoviruses encoding bispecific T cell engagers or a novel trispecific T cell engager for dual-targeting of c-MET and EGFR
This study reports a strategy to overcome immune escape of tumors during viro-immunotherapy due to tumor heterogeneity. We pursued a dual-targeting approach of epidermal growth factor receptor (EGFR) and cellular mesenchymal epithelial transition factor (c-MET) facilitated by two bispecific T cell e...
שמור ב:
| Principais autores: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2026-03-01
|
| סדרה: | Molecular Therapy: Oncology |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2950329925001754 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
